The molecular mechanism(s) which govern tissue and developmental specificity of human beta-globin gene regulation has been studied in K562 cells, a human erythroleukemia cell line that expresses high levels of embryonic and fetal globins beta-""""""""like"""""""" globin. Structural analysis, including gel mobility shift and DNAse I hypersensitive footprinting techniques, revealed that the 5' upstream regulatory region of the beta-globin gene contains three structural motifs (-530, -302, -289) that are bound by two putative trans-acting factors, termed beta-protein 1 and beta-protein 2 (BP1, BP2). In situ mutagenesis of each structural motif introduced into a reporter vector containing chloramphenicol acetyltransferase (pCAT) followed by transient transfection into hemin-induced K562 cells yielded increased levels of CAT activity as much as 5.5-fold (ranging from 49% to 68% CAT induction, p<0.001) compared to wild type (wt) & RSVCAT and therefore further confirmed these distal promoter sequences as silencers of beta-globin expression. Mutagenesis of all three cis-acting elements however, resulted in CAT activity lower than wt beta-CAT (5% versus 13%, p less than 0.05). Sequence analysis revealed the beta -globin motifs for BP1 and BP2 have overlapping binding sites with the chromosomal high mobility group protein (HMG1+2), a non sequence-specific DNA-binding and - bending factor shown here by circular permutation analysis to extrinsically bend the beta-globin gene. In theory, the removal of BP1 and BP2 binding sites also disturbed the binding of HMG1+2 and thus impeded DNA-protein and/or protein-protein interactions needed to facilitate gene expression. In order to further characterize the tertiary complex between the beta - globin cis-acting elements with BP1, BP2, and HMG1+2 proteins, chimeric constructs were created. Placing proximal BP1 and BP2 binding sites in either a cis- or trans- position to each other (by inserting 1/2 or 1 full turn of DNA, respectively) did not markedly affect beta -globin silencing, suggesting the silencing function does not require specific proximal protein-protein interaction. However, inserting an arbitrary 22 bp fragment (creating two full turns of DNA) increased gene expression 3- fold compared to wt beta -expression levels, indicating proximal BP1 and BP2 spatial constraints required for optimal silencing. This negative distance constraint could be overcome by inserting a HMG1+2 DNA motif (which also correlates to the addition of two full turns of DNA) shown here to induce DNA flexure in the beta- globin gene, re-established BP1-BP2 silencing stabilization. Through the study of the combinatorial DNA cis-acting elements and trans-acting factors, a molecular mechanism for the developmental silencing of the human adult beta globin gene repression is evolving.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK027003-01
Application #
6105180
Study Section
Medicinal Chemistry B Study Section (MCHB)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code